Objective: To investigate the efficacy of acid suppressant drugs in the empirical treatment of gastroesophageal reflux disease (GERD) and in the treatment of endoscopy-negative reflux disease (ENRD).
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.
The most frequently prescribed PPIs include omeprazole (Prilosec) and pantoprazole (Protonix). Studies show they are ...
Acid reflux, especially at night, can be difficult to manage. Here's why it happens and how it can affect your sleep quality.
Acid reflux ... in your stomach backs up into the esophagus, tube that carries food from your mouth to your stom­ach. Another term for acid reflux is “gastroesophageal reflux disease ...
Acidic foods and drinks such as tomatoes, pineapple, and coffee may trigger symptoms in people with certain conditions. Find ...
In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert ...
You can be constipated and have acid reflux at the same time. This article examines constipation as a cause and risk factor ...
November is National Stomach Cancer Awareness Month, also known as Gastric Cancer, and Bay County has an incidence rate of ...
This nod came after Dr. Reddy’s laboratories presented the bioequivalence study report before the committee. Esomeprazole is ...